A meta-analysis of individual participant data from randomized controlled trials of NSAIDs, including both traditional NSAIDs and selective COX-2 inhibitors (coxibs) showed that NSAID use was associated with an increased risk of major vascular events, such as heart attack and stroke, especially at high doses and with long-term use. The gene discussed is PTGS2; the disease is myocardial infarction.